FDA 483 - Cardinal Health 414, Inc. - June 13, 2025

Cardinal Health 414, Inc., a PET Drug Manufacturer in Seattle, WA, was cited for failing to establish adequate written quality assurance procedures. The firm lacked defined time limits for initiating non-conformance records after an observation and did not properly document the date these records were initiated. This indicates deficiencies in their quality system and record-keeping practices.